Literature DB >> 24859010

Factors associated with pregnancy attempts among female young adult cancer survivors.

Sally A Dominick1, Brian W Whitcomb, Jessica R Gorman, Jennifer E Mersereau, Karine Chung, H Irene Su.   

Abstract

PURPOSE: Little is known about pregnancy attempts among female young cancer survivors (YCS). We sought to determine fertility preservation (FP), demographic, cancer, and reproductive characteristics associated with pregnancy attempts after cancer.
METHODS: We recruited 251 female YCS (ages 18-44) to complete a survey on reproductive health outcomes. We used log-binomial regression models to estimate relative risks (RR) for characteristics associated with pregnancy attempts.
RESULTS: For the entire cohort, median time since cancer diagnosis was 2.4 years (interquartile range 4.0). Fifty-two YCS (21%) attempted pregnancy after cancer diagnosis. In unadjusted analyses, lack of FP therapy prior to cancer treatment, older age, partnered relationship, higher income, no history of stem cell or bone marrow transplant, and longer duration of survivorship were significantly associated with pregnancy attempts. In multivariable analyses, YCS who did not undergo FP therapy were more than twice as likely to attempt pregnancy as those who did undergo FP therapy (RR 2.4, 95% confidence interval (CI) 1.3, 4.3). Partnered status (RR 7.1, 95% CI 2.5, 20.2) and >2 years since cancer diagnosis (RR 2.3, 95% CI 1.3, 4.1) were also significantly associated with attempts.
CONCLUSIONS: In YCS, milestones including partnered relationships and longer duration of cancer survivorship are important to attempting pregnancy. A novel, inverse association between FP therapy and pregnancy attempts warrants further study. IMPLICATIONS FOR CANCER SURVIVORS: Pregnancy attempts after cancer were more likely after attaining both social- and cancer-related milestones. As these milestones require time, YCS should be made aware of their potential for concomitant, premature loss of fertility in order to preserve their range of fertility options.

Entities:  

Mesh:

Year:  2014        PMID: 24859010      PMCID: PMC4221647          DOI: 10.1007/s11764-014-0369-z

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  44 in total

1.  Emerging adulthood. A theory of development from the late teens through the twenties.

Authors:  J J Arnett
Journal:  Am Psychol       Date:  2000-05

2.  Health status of adolescent and young adult cancer survivors.

Authors:  Eric Tai; Natasha Buchanan; Julie Townsend; Temeika Fairley; Angela Moore; Lisa C Richardson
Journal:  Cancer       Date:  2012-06-11       Impact factor: 6.860

Review 3.  Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.

Authors:  Jessica Howard-Anderson; Patricia A Ganz; Julienne E Bower; Annette L Stanton
Journal:  J Natl Cancer Inst       Date:  2012-01-23       Impact factor: 13.506

4.  Breast cancer adjuvant therapy: time to consider its time-dependent effects.

Authors:  Ismail Jatoi; William F Anderson; Jong-Hyeon Jeong; Carol K Redmond
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

5.  Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

Authors:  Michael Gnant; Brigitte Mlineritsch; Herbert Stoeger; Gero Luschin-Ebengreuth; Dietmar Heck; Christian Menzel; Raimund Jakesz; Michael Seifert; Michael Hubalek; Gunda Pristauz; Thomas Bauernhofer; Holger Eidtmann; Wolfgang Eiermann; Guenther Steger; Werner Kwasny; Peter Dubsky; Gerhard Hochreiner; Ernst-Pius Forsthuber; Christian Fesl; Richard Greil
Journal:  Lancet Oncol       Date:  2011-06-05       Impact factor: 41.316

6.  Factors influencing women's decisions about timing of motherhood.

Authors:  Karen Benzies; Suzanne Tough; Karen Tofflemire; Corine Frick; Alexandra Faber; Christine Newburn-Cook
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2006 Sep-Oct

Review 7.  The psychosocial impact of cancer-related infertility on women: a review and comparison.

Authors:  Rebecca Penrose; Lisa Beatty; Julie Mattiske; Bogda Koczwara
Journal:  Clin J Oncol Nurs       Date:  2013-04       Impact factor: 1.027

Review 8.  Fertility (male and female) and menopause.

Authors:  Kathryn J Ruddy; Ann H Partridge
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

9.  Hormonal therapies in young breast cancer patients: when, what and for how long?

Authors:  Alexandre Christinat; Simona Di Lascio; Olivia Pagani
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 10.  Studying time to pregnancy by use of a retrospective design.

Authors:  Michael Joffe; Jane Key; Nicky Best; Niels Keiding; Thomas Scheike; Tina Kold Jensen
Journal:  Am J Epidemiol       Date:  2005-06-22       Impact factor: 4.897

View more
  4 in total

1.  Contraceptive Practices Among Female Cancer Survivors of Reproductive Age.

Authors:  Sally A Dominick; Mamie R McLean; Brian W Whitcomb; Jessica R Gorman; Jennifer E Mersereau; Janet M Bouknight; H Irene Su
Journal:  Obstet Gynecol       Date:  2015-09       Impact factor: 7.661

Review 2.  Best Practices in Counseling Young Female Cancer Survivors on Reproductive Health.

Authors:  Ksenya Shliakhtsitsava; Deepika Suresh; Tracy Hadnott; H Irene Su
Journal:  Semin Reprod Med       Date:  2017-10-16       Impact factor: 1.303

3.  Use of emergency contraception among female young adult cancer survivors.

Authors:  Alexa C O Medica; Shaylyn S Stark; Tracy N Hadnott; Andrew C Dietz; Sally A D Romero; Loki Natarajan; Elena Martinez; Brian W Whitcomb; H Irene Su
Journal:  Fertil Steril       Date:  2018-06       Impact factor: 7.329

4.  Cancer survivors of gynecologic malignancies are at risk for decreased opportunity for fertility preservation.

Authors:  Wael H Salem; Joe M Letourneau; Jessica Chan; Sai-Wing Chan; Marcelle Cedars; Mitchell P Rosen
Journal:  Contracept Reprod Med       Date:  2017-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.